Patents by Inventor WAEL JDEY

WAEL JDEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A DBAIT MOLECULE IN COMBINATION WITH KRAS INHIBITOR FOR THE TREATMENT OF CANCER
    Publication number: 20230235327
    Abstract: The present invention relates to the combination of a Dbait molecule with a KRAS inhibitor for treating cancer.
    Type: Application
    Filed: June 4, 2021
    Publication date: July 27, 2023
    Inventors: WAEL JDEY, FRANÇOISE BONO
  • Use of a combination of Dbait molecule and PARP inhibitors to treat cancer
    Patent number: 11162095
    Abstract: The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: November 2, 2021
    Assignees: INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ONXEO, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PARIS-SUD 11
    Inventors: Marie Dutreix, Wael Jdey
  • A DBAIT MOLECULE AGAINST ACQUIRED RESISTANCE IN THE TREATMENT OF CANCER
    Publication number: 20200407720
    Abstract: The invention relates to a method for delaying and/or preventing development of cancer resistant to a cancer therapy agent in a patient based on administration of a Dbait molecule.
    Type: Application
    Filed: March 12, 2019
    Publication date: December 31, 2020
    Inventors: FRANÇOISE BONO, WAEL JDEY, MARIE DUTREIX
  • USE OF A COMBINATION OF DBAIT MOLECULE AND PARP INHIBITORS TO TREAT CANCER
    Publication number: 20200172901
    Abstract: The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 4, 2020
    Inventors: MARIE DUTREIX, WAEL JDEY
  • Use of a combination of Dbait molecule and PARP inhibitors to treat cancer
    Patent number: 10563197
    Abstract: The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: February 18, 2020
    Assignees: INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ONXEO, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PARIS-SUD 11
    Inventors: Marie Dutreix, Wael Jdey
  • USE OF A COMBINATION OF DBAIT MOLECULE AND PARP INHIBITORS TO TREAT CANCER
    Publication number: 20180362972
    Abstract: The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.
    Type: Application
    Filed: July 22, 2016
    Publication date: December 20, 2018
    Inventors: MARIE DUTREIX, WAEL JDEY